XML 118 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Information by segment and main country
12 Months Ended
Dec. 31, 2019
Information by segment and main country [Abstract]  
Information by segment and main country [Text block]

2Information by segment and main country

Philips Group

Information on income statements

in millions of EUR

2017 - 2019

sales

sales including intercompany

depreciation and amortization1)

Adjusted EBITA2)3)

2019

Diagnosis & Treatment4)

8,485

8,579

(564)

1,078

Connected Care

4,674

4,760

(327)

618

Personal Health

5,854

5,864

(186)

943

Other

469

542

(326)

(76)

Inter-segment eliminations

(263)

Philips Group

19,482

19,482

(1,402)

2,563

2018

Diagnosis & Treatment

7,726

7,825

(349)

872

Connected Care

4,341

4,516

(326)

662

Personal Health

5,524

5,538

(171)

860

Other

530

612

(244)

(28)

Inter-segment eliminations

(369)

Philips Group

18,121

18,121

(1,089)

2,366

2017

Diagnosis & Treatment

7,365

7,445

(301)

747

Connected Care

4,331

4,492

(355)

684

Personal Health

5,685

5,702

(181)

879

Other

400

535

(188)

(157)

Inter-segment eliminations

(393)

Philips Group

17,780

17,780

(1,025)

2,153

1)Includes impairments; for impairment values please refer to Property, plant and equipment and Intangible assets excluding goodwill
2)Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.
3)For reconciliation Adjusted EBITA, refer to the table below.
4)In 2019 Philips’ Emerging Businesses were moved out of segment Other into segment Diagnosis & Treatment to enable these businesses with better access to downstream capabilities. While these businesses remain in (semi-)incubator phase, in 2019 they received a corporate funding out of segment Other of EUR 54 million to support them during their emerging idea-to-market business phase.

As required by IFRS 8 Operating Segments, Philips operating segments are Diagnosis & Treatment businesses, Connected Care businesses and Personal Health businesses, each being responsible for the management of its business worldwide. From January 1, 2019, Philips realigned the composition of its reporting segments. The most notable changes are the shifts of the Sleep & Respiratory Care business from the Personal Health segment to the renamed Connected Care segment and most of the Healthcare Informatics business from the renamed Connected Care segment to the Diagnosis & Treatment segment. The 2018 and 2017 segment results have been reclassified according to the revised reporting structure.

Philips focuses on improving people’s lives through meaningful innovation across the health continuum – from healthy living and prevention to diagnosis, treatment and home care. The Diagnosis & Treatment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. The Connected Care businesses focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways, and leveraging provider-payer-patient business models. The Personal Health businesses focuses on healthy living and preventative care.

The Executive Committee of Philips is deemed to be the chief operating decision maker (CODM) for IFRS 8 segment reporting purposes. The key segmental performance measure is Adjusted EBITA*), which Management believes is the most relevant measure to evaluate the results of the segments.

The term Adjusted EBITA*) is used to evaluate the performance of Philips and its segments. EBITA*) represents Income from operations excluding amortization and impairment of acquired intangible assets and impairment of goodwill. Adjusted EBITA*) represents EBITA *)excluding gains or losses from restructuring costs, acquisition-related charges and other items.

Adjusted EBITA*) is not a recognized measure of financial performance under IFRS. Below is a reconciliation of Adjusted EBITA*) to the most directly comparable IFRS measure, Net income, for the years indicated. Net income is not allocated to segments as certain income and expense line items are monitored on a centralized basis, resulting in them being shown on a Philips Group level only.

Philips Group

Reconciliation from net income to Adjusted EBITA1)

In millions of EUR

2017 - 2019

Philips Group

Diagnosis & Treatment

Connected Care

Personal Health

Other

2019

Net Income

1,173

Discontinued operations, net of income taxes

19

Income tax expense

337

Investments in associates, net of income taxes

(1)

Financial expenses

233

Financial income

(117)

Income from operations

1,644

660

267

844

(127)

Amortization of intangible assets

350

177

141

25

8

Impairment of goodwill

97

19

78

EBITA1)

2,091

856

486

869

(119)

Restructuring and acquisition-related charges

318

149

64

50

54

Other items

153

73

67

23

(11)

Adjusted EBITA1)

2,563

1,078

618

943

(76)

2018

Net Income

1,097

Discontinued operations, net of income taxes

213

Income tax expense

193

Investments in associates, net of income taxes

2

Financial expenses

264

Financial income

(51)

Income from operations

1,719

629

399

796

(105)

Amortization of intangible assets

347

98

140

31

79

EBITA1)

2,066

727

539

827

(27)

Restructuring and acquisition-related charges

258

146

66

15

31

Other items

41

-

56

18

(33)

Adjusted EBITA1)

2,366

872

662

860

(28)

2017

Net Income

1,870

Discontinued operations, net of income taxes

(843)

Income tax expense

349

Investments in associates, net of income taxes

4

Financial expenses

263

Financial income

(126)

Income from operations

1,517

512

424

834

(252)

Amortization of intangible assets

260

57

138

39

26

Impairment of goodwill

9

9

EBITA1)

1,787

568

562

873

(217)

Restructuring and acquisition-related charges

316

156

91

6

64

Other items

50

22

31

(3)

Adjusted EBITA1)

2,153

747

684

879

(157)

1)Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.

Transactions between the segments are mainly related to components and parts included in the product portfolio of the other segments. The pricing of such transactions was at cost or determined on an arm’s length basis. Philips has no single external customer that represents 10% or more of sales.

Philips Group

Main countries

in millions of EUR

2017 - 2019

sales1)

tangible and intangible assets2)

2019

Netherlands

522

2,148

United States

6,667

9,864

China

2,707

340

Japan

1,186

550

Germany

1,087

308

France

505

46

United Kingdom

470

611

Other countries

6,338

1,119

Total main countries

19,482

14,986

2018

Netherlands

510

1,666

United States

6,050

9,493

China

2,380

353

Japan

1,045

491

Germany

1,032

263

France

519

30

South Korea

498

3

Other countries

6,087

1,506

Total main countries

18,121

13,805

2017

Netherlands

414

1,154

United States

6,084

8,408

China

2,322

959

Japan

1,059

457

Germany

1,011

270

France

530

33

India

425

100

Other countries

5,935

1,263

Total main countries

17,780

12,644

1)The sales are reported based on country of destination.
2)Consists of Property plant and equipment, Intangible assets excluding goodwill and Goodwill
*)Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.